Search Results 1-10 of 10071 for SC

  1. A Study of SC-007 in Subjects With Advanced Cancer - Mayo Clinic

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...

  2. SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the efficacy non-inferiority between isatuximab SC and isatuximab IV in combination with ...

  3. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  4. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

    In Part B (dose expansion), potential therapeutic doses may be studied with SC-004 as monotherapy and SC-004 in combination with ABBV-181 in disease-specific ...

  5. Efgartigimod PH20 SC in Participants Aged 18 Years and Older With Active Idiopathic Inflammatory Myopathy - Mayo Clinic

    Secondary objectives include efficacy measures of efgartigimod PH20 SC in participants with IIM. IIM is a disease of the immune system that causes weakness of ...

  6. Carolinas Hospital System joins Mayo Clinic Care Network

    FLORENCE, S.C. – Carolinas Hospital System and Mayo Clinic announced today that Carolinas Hospital System has joined the Mayo Clinic Care Network, a growing ...

  7. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult ...

  8. Pasireotide s.c. in Patients with Post-Bariatric Hypoglycaemia - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of pasireotide s.c. on level 2 hypoglycaemic events after a mixed meal tolerance test (MMTT) in patients ...

  9. A Study of the Safety of Joint Injected Sc-rAAV2.5IL-1Ra (a Virus Carried Gene Therapy) in Patients with Moderate Knee Osteoarthritis - Mayo Clinic

    The purpose of this study is to determine the safety of sc-rAAV2.5IL-1Ra, a gene therapy carried by a virus and delivered by injection into the knee joint of ...

  10. Michael Camilleri, M.D., D.Sc. - Mayo Clinic Faculty Profiles

    Irritable bowel syndrome and chronic constipation. These conditions account for 25 percent of all patients presenting to gastroenterologists. Dr. Camilleri ...